Does Donepezil Improve Well-Being for Dementia due to Alzheimer’s Disease?

Publisher： Karger

E-ISSN： 1423-0208|24|3|168-169

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.24, Iss.3, 2005-04, pp. : 168-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Does Rivastigmine Improve Cognitive Functions or Disability in Patients with Alzheimer’s Disease?

By  

Neuroepidemiology, Vol. 23, Iss. 4, 2004-07 ,pp. : 209-210

Karger

Access to resources Recommend Favorite

The Efficacy of Licensed-Indication Use of Donepezil and Memantine Monotherapies for Treating Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Systematic Review and Meta-Analysis

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-07 ,pp. : 212-227

Karger

Access to resources Recommend Favorite

Economic Evaluation of Donepezil Treatment for Alzheimer’s Disease in Japan

By  

Dementia and Geriatric Cognitive Disorders, Vol. 13, Iss. 1, 2001-12 ,pp. : 33-39

Karger

Access to resources Recommend Favorite

Chronic Donepezil Treatment Is Associated with Slowed Cognitive Decline in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 4, 2001-05 ,pp. : 295-300

Karger

Access to resources Recommend Favorite

The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 3, 1999-05 ,pp. : 237-244

Karger

Access to resources Recommend Favorite